You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the ASCOR (ascorbic acid) Drug Profile, 2024 PDF Report in the Report Store ~

ASCOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ascor, and what generic alternatives are available?

Ascor is a drug marketed by Mcguff and is included in one NDA.

The generic ingredient in ASCOR is ascorbic acid. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ASCOR?
  • What are the global sales for ASCOR?
  • What is Average Wholesale Price for ASCOR?
Summary for ASCOR
Drug patent expirations by year for ASCOR
Drug Prices for ASCOR

See drug prices for ASCOR

Pharmacology for ASCOR
Drug ClassVitamin C

US Patents and Regulatory Information for ASCOR

ASCOR is protected by zero US patents and one FDA Regulatory Exclusivity.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcguff ASCOR ascorbic acid SOLUTION;INTRAVENOUS 209112-001 Oct 2, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ASCOR Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Ascorbic Acid (ASCOR)

Market Size and Growth Projections

The global ascorbic acid market is poised for significant growth in the coming years. As of 2021, the market was valued at approximately $1.3 billion, and it is projected to reach $2.2 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5.2% from 2022 to 2031[4].

Another report indicates that the market size is expected to reach $1.61 billion by 2028, growing at a CAGR of 5.0% during the forecast period[1].

Key Drivers of Market Growth

Several factors are driving the growth of the ascorbic acid market:

  • Increasing Use in Food and Beverages: Ascorbic acid is widely used as a preservative and antioxidant in food products, particularly in bakery items, canned goods, fruit juices, and frozen fruits. This segment is expected to dominate the market in terms of revenue growth due to the growing demand for canned and ready-to-eat foods[1].

  • Cosmetic and Skincare Applications: The rising popularity of anti-aging serums, creams, and other cosmetic products containing vitamin C is a significant driver. Ascorbic acid's role in enhancing skin health and reducing signs of aging contributes to its increasing demand in the cosmetics industry[1].

  • Pharmaceutical and Medical Uses: Ascorbic acid is used intravenously to treat chronic conditions and has shown potential in cancer therapy due to its anti-cancer and cytotoxic activities. This medical application is another key driver of market growth[1].

  • Dietary Supplements: The increasing consumer preference for dietary vitamin supplements also contributes to the market's expansion[1].

Segmentation and Revenue Share

The ascorbic acid market can be segmented into various types, forms, and applications:

  • Sodium Ascorbate Segment: This segment is expected to account for the largest revenue share due to the growing use of sodium ascorbate as an antioxidant in food products, its increasing approval from regulatory authorities, and its use as a stabilizer and conditioner in bakery items[1].

  • Food Grade Segment: The food grade segment is expected to register significant revenue growth due to the rising use of food grade ascorbic acid in fruit juices, frozen fruits, and as a chemical preservative in food products[1].

  • Tablet Segment: The tablet segment will account for a considerable revenue share due to the increasing prescription of oral doses of vitamin C to treat infections and chronic diseases, as well as the availability of extended-release and chewable tablets[1].

Regional and Global Market Players

The global ascorbic acid market is characterized by the presence of several key players, including Pharmavit, Luwei Pharmaceutical Group Co., Ltd, Reckon Organics Private Ltd., Bactolac Pharmaceutical Inc., and others. These companies are involved in various aspects of the market, from production to distribution, and play a crucial role in shaping the market dynamics[4].

Financial Trajectory and Pricing

The financial trajectory of ascorbic acid is influenced by its various applications and the pricing strategies in different markets:

  • Pricing for Pharmaceutical Use: For instance, the cost for Ascor (ascorbic acid) intravenous solution can range from $294 for a supply of 50 milliliters to $7,046 for 1250 milliliters (25 x 50 milliliters), depending on the pharmacy and the quantity purchased[2].

  • Discounts and Patient Assistance Programs: There are discount cards and copay programs available that can significantly reduce the cost of ascorbic acid for patients. However, no patient assistance programs specifically for Ascor were found[2].

Research and Development

Extensive research and development activities are ongoing to explore the various applications of ascorbic acid. These include studies on its anti-cancer and cytotoxic activities, which have provided evidence of its potential in cancer therapy. Such research is expected to further boost the market growth by expanding the range of applications for ascorbic acid[1].

Regulatory Approvals and Compliance

The regulatory environment plays a crucial role in the market dynamics of ascorbic acid. For example, the FDA has approved ascorbic acid for the short-term treatment of scurvy, and there are ongoing reviews and recommendations for packaging and labeling to ensure medication safety and reduce drug wastage[5].

Key Takeaways

  • The global ascorbic acid market is projected to grow significantly, reaching $2.2 billion by 2031.
  • Key drivers include increasing use in food and beverages, cosmetic applications, pharmaceutical uses, and dietary supplements.
  • The sodium ascorbate and food grade segments are expected to contribute significantly to revenue growth.
  • Pricing varies widely depending on the form and quantity of ascorbic acid.
  • Research and development activities are expanding the potential applications of ascorbic acid.
  • Regulatory compliance is crucial for ensuring safety and reducing drug wastage.

Frequently Asked Questions (FAQs)

Q: What is the projected market size of the global ascorbic acid market by 2031? A: The global ascorbic acid market is projected to reach $2.2 billion by 2031[4].

Q: What are the primary drivers of the ascorbic acid market growth? A: The primary drivers include increasing use in food and beverages, cosmetic applications, pharmaceutical uses, and dietary supplements[1].

Q: Which segment is expected to account for the largest revenue share in the ascorbic acid market? A: The sodium ascorbate segment is expected to account for the largest revenue share due to its growing use as an antioxidant and stabilizer[1].

Q: How much does Ascor (ascorbic acid) intravenous solution cost? A: The cost for Ascor intravenous solution can range from $294 for 50 milliliters to $7,046 for 1250 milliliters, depending on the quantity and pharmacy[2].

Q: Are there any patient assistance programs available for Ascor? A: No patient assistance programs specifically for Ascor were found, although discount cards and copay programs can reduce costs[2].

Cited Sources

  1. Reports and Data: Ascorbic Acid Market Size to Reach USD 1.61 Billion in 2028, Says Reports and Data.
  2. Drugs.com: Ascor Prices, Coupons, Copay Cards & Patient Assistance.
  3. Fourth-Quarter 2022 Earnings Conference Call Prepared Remarks: Pfizer.
  4. Allied Market Research: Ascorbic Acid Market Size, Share, Growth, Price | Forecast, 2031.
  5. FDA: Label and Labeling Review for Ascor (NDA 209112).

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.